Clinical Trials on Post Renal Transplantation

Total 18060 results

Wyeth is now a wholly owned subsidiary of Pfizer

Terminated

Study Evaluating Rapamune in Patients After Kidney Transplantation

Renal Transplantation

Germany
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Evaluating Sirolimus and Cyclosporine in Kidney Transplant Recipients

Renal Transplantation
University Hospital Schleswig-Holstein

Unknown

Induction of Donor-Specific Tolerance in Renal Allograft Recipients (Living Donor) With TAIZ-Monocytes

Renal Transplantation

Germany
University Hospital Schleswig-Holstein

Completed

Investigation of the Steady State Pharmacokinetics of Sirolimus, Mycophenolat Mofetil and Fluvastatin After Renal Transplantation

Renal Transplantation
Assistance Publique - Hôpitaux de Paris

Not yet recruiting

Assesment the Efficacy of Dd-cfDNA in Routine Patient Care in Kidney Transplant Recipients" (AI-CARE)

Renal Transplantation

France
ITB-Med LLC

Recruiting

A Study of TCD601 in de Novo Renal Transplant Recipients (ASCEND)

Renal Transplantation

United States
Hospices Civils de Lyon

Active, not recruiting

3-month Screening Biopsy to Optimize the Immunosuppression in Renal Transplantation (I4BiS)

Renal Transplantation

France
University Hospital, Montpellier

Completed

Endothelial Microparticules and Antibody Mediated Rejection and Kidney Transplantation: Biomarker of Antibody-mediated Rejection in Kidney Transplantation (MICROMARK RJ)

Renal Transplantation

France
Novartis Pharmaceuticals

Completed

Efficacy, Safety, Tolerability, and Pharmacokinetics of Sotrastaurin Combined With Tacrolimus vs. a Mycophenolic Acid-tacrolimus Regimen in Renal Transplant Patients

Renal Transplantation

United States, Germany, United Kingdom, Belgium, Australia, Hungary, Netherlands, Sweden, Colombia, Argentina, Brazil, Canada, Denmark, Korea, Republic of, Portugal
Medical University of Vienna
Novartis

Completed

Identification of Patients With High Probability of Poorly Responding to Therapy With Mycophenolic Acid Prodrugs

Renal Transplantation

Austria
University Hospital, Brest

Unknown

Comparison Thymoglobulin® and Grafalon® (THYGRET)

Renal Transplantation

France
Bristol-Myers Squibb

Completed

A Study to Compare the Pharmacokinetics of Belatacept Using Active Pharmaceutical Ingredient Manufactured by Process E Relative to Process C

Renal Transplantation

United States
Assiut University

Unknown

Outcome of Living Donor Renal Transplantation in Assiut Urology and Nephrology University Hospital ,Initial Experience

Renal Transplantation

Egypt
Novartis

Completed

Efficacy and Safety of Enteric-coated Mycophenolate Sodium (EC-MPS) in de Novo Kidney Transplant Recipients

Renal Transplantation

Switzerland
Novartis Pharmaceuticals

Completed

Efficacy and Safety of FTY720 Versus Mycophenolate Mofetil (MMF, Roche Brand) in de Novo Adult Renal Transplant Recipients

Renal Transplantation
Novartis Pharmaceuticals
Mitsubishi Tanabe Pharma Corporation

Completed

Efficacy and Safety of FTY720 in de Novo Adult Renal Transplant Recipients

Renal Transplantation
Hospices Civils de Lyon

Completed

Catalytic Antibodies to Predict Uninvasively Late Transplant Failure (CATAPULT)

Renal Transplantation

France
CHU de Reims

Unknown

Contribution of Diffusion MRI in Renal Graft Transplantation

Renal Transplantation

France
Hoffmann-La Roche

Completed

Study Comparing Efficacy and Safety of Mycophenolate Mofetil (Cellcept) With Delayed Introduction of Sirolimus and Discontinuation of Cyclosporine, With Those of Mycophenolate Mofetil and Long Term Continuation of Cyclosporine in Renal Transplant Recipients

Renal Transplantation

France
Irmandade Santa Casa de Misericórdia de Porto Alegre
Novartis

Completed

A Prospective Study to Investigate Mycophenolic Acid (MPA) Exposure Through Area Under the Curve (AUC) in Renal Transplants Recipients Treated With Mycophenolate Mofetil (MMF) and After Conversion to Mycophenolate Sodium (EC-MPS) (AUC-MPA)

Renal Transplantation

Brazil
Novartis Pharmaceuticals

Completed

ASCERTAIN: Assessment of Everolimus in Addition to Calcineurin Inhibitor Reduction in the Maintenance of Renal Transplant Recipients

Renal Transplantation

Switzerland
University of Oslo School of Pharmacy
Rikshospitalet University Hospital

Completed

Computer Guided Doing of Tacrolimus in Renal Transplantation (OPTIMAL)

Renal Transplantation

Norway
Centre Hospitalier Universitaire de Nice

Completed

AADAPT - Analysis of Advagraf Dose Adaptation Post Transplantation (AADAPT)

Renal Transplantation

France
Novartis Pharmaceuticals

Completed

Pharmacodynamics, Efficacy and Safety of Basiliximab 40 or 80 mg in Combination With Ciclosporine Microemulsion or Everolimus, in Adult Low Risk de Novo Renal Transplant Recipients (IDEALE Study) (IDEALE)

Renal Transplantation

France
Novartis Pharmaceuticals

Terminated

Study to Evaluate the Efficacy, Safety and Tolerability of Everolimus in de Novo Renal Transplant Recipients Participating in the Eurotransplant Senior Program (Senator)

Renal Transplantation

Germany
Novartis

Completed

Efficacy and Safety of Everolimus With Enteric-Coated Mycophenolate Sodium (EC-MPS) in a Cyclosporine Microemulsion-free Regimen Compared to Standard Therapy in de Novo Renal Transplant Patients

Renal Transplantation

Switzerland, Germany
Novartis Pharmaceuticals

Terminated

A Study Designed to Compare the Tolerability of an Increased Dose of Enteric-coated Mycophenolate Acid (MPA) in Renal Transplant Patients Whose Dose of Mycophenolate Mofetil (MMF) Was Reduced Due to Gastrointestinal Symptoms

Renal Transplantation

United States
University of Wisconsin, Madison

Completed

MMF Monotherapy and Immune Regulation in Kidney Transplant Recipients: Part 1 Steroid Withdrawal

Renal Transplantation

United States
The Second Artillery General Hospital
Capital Medical University; Shanghai Changzheng Hospital; Air Force General Hospital... and other collaborators

Completed

Initial Dosage Range of Tacrolimus by Genotyping in Chinese Renal Transplantation (PSIDRTG)

Renal Transplantation

China
Novartis Pharmaceuticals

Completed

Long Term Efficacy and Safety of FTY720 in de Novo Adult Renal Transplant Recipients

Renal Transplantation
Brigham and Women's Hospital
Genzyme, a Sanofi Company

Completed

Characterization of Immunological Profile of Renal Transplant Patients Undergoing Induction Treatment With Thymoglobulin vs. IL-2 Receptor Antagonist Basiliximab

Renal Transplantation

United States
Novartis Pharmaceuticals

Completed

Intensified vs. Standard Dose Therapy With Mycophenolate Sodium Plus Cyclosporin Microemulsion and Corticosteroid Combination in Patients With de Novo Renal Transplant Patients

Renal Transplantation

Germany
Wyeth is now a wholly owned subsidiary of Pfizer

Completed

Study Comparing Conversion to Sirolimus vs. Continued Use of Calcineurin Inhibitors in Kidney Transplant Recipients

Renal Transplantation
University Hospital Muenster
Else Kröner Fresenius Foundation

Completed

Influence of Sirolimus and MMF on Vascular Function and Markers of Cellular Function in Renal Transplant Recipients

Renal Transplantation

Germany
University Hospital, Antwerp
Novartis Pharmaceuticals; University of Liege; University Hospital, Ghent; Universitair... and other collaborators

Unknown

Calcineurin Inhibitor (CNI) Versus Steroid Cessation in Renal Transplantation (CISTCERT)

Renal Transplantation

Belgium
Shiraz University of Medical Sciences

Completed

The Effect of Simvastatin on Desensitization of Panel-Positive Kidney Transplant Candidates

Renal Transplantation

Iran, Islamic Republic of
Novartis

Completed

Safety and Tolerability of Enteric-Coated Mycophenolate Sodium (EC-MPS) in Renal Transplant Patients With GI Intolerance

Renal Transplantation

United States
University Hospital Schleswig-Holstein

Completed

Investigation of the Steady State Pharmacokinetics of Tacrolimus, Mycophenolate Mofetil and Fluvastatin After Renal Transplantation

Renal Transplantation
Memorial Sloan Kettering Cancer Center
City University of New York

Active, not recruiting

Adaptation of Skills Training Manuals for Patients Receiving Hematopoietic Stem Cell Transplantation and Their Caregivers

Post Hematopoietic Stem Cell Transplantation

United States
Eduardo Schiffer

Not yet recruiting

Dexmedetomidine and Kidney Transplantation (DexTR)

Dexmedetomidine | Renal Transplantation
Alexandria University

Completed

Hypomagnesemia and Its Association With Calcineurin Inhibitors Use in Renal Transplant Recipients

Renal Transplantation; Complication

Egypt
VA Office of Research and Development

Terminated

Pneumococcal Conjugate Vaccine in Aging Renal Transplant

Aging | Renal Transplantation

United States
University of Florida
Hoffmann-La Roche

Completed

MPA PK Monitoring Strategy With MMF/FK Based Immunosuppression

Immunosuppression | Transplantation, Renal

United States
Novartis

Completed

Study of Enteric-Coated Mycophenolate Sodium (EC-MPS) Plus Reduced-dose Cyclosporine Microemulsion (CsA-ME) Compared to EC-MPS Plus Standard Dose CsA-ME in Eldery de Novo Renal Transplant Recipients Treated With Basiliximab and Short-term Steroids

Denovo Renal Transplantation
Swedish Medical Center
Genzyme, a Sanofi Company

Completed

Thymoglobulin: Presence and Affect in the Central Lymphatic Compartment

Immunosuppression | Renal Transplantation

United States
Novartis

Completed

Study of Enteric-coated Mycophenolate Sodium Maintenance Therapy in Patients With Renal Transplant Receiving Cyclosporine Microemulsion and Steroids,

Maintenance Renal Transplantation
Washington University School of Medicine

Completed

Renal Transplantation With Immune Monitoring

Immunosuppression | Renal Transplantation

United States
National Cancer Institute (NCI)

Completed

Cancer Risk in Organ Transplant Recipients and End-Stage Renal Disease

Cancer | Organ Transplantation | Immunocompromised Host

United States
Klemens Budde
Charite University, Berlin, Germany; DESCARTES Working Group On Transplantation and other collaborators

Unknown

Efficacy and Safety of a Reduced Immunosuppression vs. Standard Triple Therapy in Senior Renal Transplant Recipients (REDUCE)

Immunosuppression After Renal Transplantation
Amgen

Completed

Treatment of Autonomous Hyperparathyroidism in Post Renal Transplant Recipients

Hyperparathyroidism | End Stage Renal Disease | Chronic Kidney Disease | Kidney Transplantation | Chronic Renal Failure | Hypophosphatemia | Kidney Disease | Chronic Allograft Nephropathy | Disordered Mineral Metabolism | Post Renal Transplantation

United States, Canada, France, Italy, Belgium, Switzerland, Spain, Australia, Germany, Austria, Poland

3

Subscribe